Results 221 to 230 of about 288,387 (304)

Safety of short-term non-steroidal anti-inflammatory drug use in the postoperative setting in paediatric patients with chronic kidney disease: protocol for a randomised, placebo-controlled trial. [PDF]

BMJ Open
Xiang AH, Hwang CK, Clennon E, To T, Pyrzanowski J, Calderon AB, Wilson S, Shields E, Beltran G, Sevick C, Bock M, Harris KT, Rove KO.   +12 more
europepmc   +1 more source

Changes in effectiveness and safety in patients with Lennox–Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open‐label extension study

Epilepsia Open, EarlyView.
This graphical abstract provides an overview of the content from this post hoc analysis describing the trajectories of fenfluramine effectiveness and safety, along with dose changes over time, in patients with Lennox‐Gastaut syndrome. Abstract In the phase 3 randomized controlled trial (RCT; NCT03355209) of fenfluramine in Lennox–Gastaut syndrome (LGS),
Rima Nabbout, Orrin Devinsky, Lieven Lagae, Ingrid E. Scheffer, Renzo Guerrini, Joseph Sullivan, Antonio Gil‐Nagel, Sameer M. Zuberi, Kate Riney, Patrick Healy, Jayne Abraham, Rebecca Zhang Roper, Mélanie Langlois, Amélie Lothe, Kelly G. Knupp   +14 more
wiley   +1 more source

Bora, CEP192 and Cenexin regulate distinct Plk1-dependent cell and centrosome cycle transitions. [PDF]

Nat Commun
Dwivedi D, Borges C, Harry D, Cirillo L, Meraldi P.   +4 more
europepmc   +1 more source

The aurora named STEVE is not an aurora

Nature, 2018
openaire   +1 more source

Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics

Epilepsia Open, EarlyView.
This graphical abstract provides an overview of the content from this post hoc analysis evaluating the efficacy and safety of fenfluramine in patients with Dravet syndrome stratified by age, number of previously attempted antiseizure medications, and SCN1A pathogenic variant status using data pooled from the three pivotal randomized controlled trials ...
Rima Nabbout, Joseph Sullivan, Stéphane Auvin, J. Helen Cross, Orrin Devinsky, Antonio Gil‐Nagel, Renzo Guerrini, Kelly G. Knupp, M. Scott Perry, Rocío Sánchez‐Carpintero, An‐Sofie Schoonjans, Ingrid E. Scheffer, Nicola Specchio, Adam Strzelczyk, James Wheless, Elaine C. Wirrell, Diego Morita, Patrick Healy, Mélanie Langlois, Amélie Lothe, Lieven Lagae   +20 more
wiley   +1 more source

Pulsed Field Ablation of Atypical Atrial Flutter in a Patient After Hybrid Ablation of Atrial Fibrillation. [PDF]

Clin Case Rep
Deets A, Zaman M, Nelson DW, Axtell K, Sra J.   +4 more
europepmc   +1 more source

Securing Water in a Changing Climate: A Transient Solar Desalination Model for the Sundarbans, Bangladesh

Energy Science &Engineering, EarlyView.
This graphical abstract presents a solar‐powered reverse osmosis (RO) system for the Sundarbans, Bangladesh. Mechanistic modeling reveals a critical seasonal mismatch: during the monsoon, feed water salinity peaks (24.8 ppt) while solar irradiance drops significantly.
Debasish Sarker, Md Arifuzzaman, AKM Foysal Ahmed, Sayeed Rushd   +3 more
wiley   +1 more source

Citron Kinase, a mitotic kinase with increasing significance in cancer. [PDF]

Cell Cycle
Mitri E, Callot C, Hatzoglou A, Besson A.   +3 more
europepmc   +1 more source

Pulsed wave tissue Doppler imaging of the left ventricle in foals: Feasibility, inter‐ and intra‐observer variability and wave pattern over the first days of life

Equine Veterinary Journal, EarlyView.
Abstract Background Tissue Doppler imaging (TDI) may improve the assessment of myocardial function in neonatal foals. Objectives To document the feasibility of left ventricular pulsed wave (PW) TDI, inter‐ and intra‐observer variability and wave pattern over the first 5 days of life. Study Design Prospective observational study.
Fernanda Timbó D'el Rey Dantas, Gayle Hallowell, Carolina Castagnetti, Giovanni Romito, Laura Menchetti, Aurora Mannini, Aliai Lanci, Jole Mariella, Francesca Freccero   +8 more
wiley   +1 more source

Alisertib, an Aurora Kinase a Inhibitor, Induces Apoptosis and Autophagy but Inhibits Epithelial to Mesenchymal Transition in Human Epithelial Ovarian Cancer Cells [Retraction]. [PDF]

Drug Des Devel Ther
europepmc   +1 more source